Since our results had clearly demonstrated that IL-22 enhanced aerobic glycolysis via targeting HK2 in colon cancer cells, we further explored whether HK2 accounts for IL22-mediated cancer cell proliferation. The gene discussed is IL22; the disease is colonic neoplasm.